Artigo Revisado por pares

An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry

2024; Elsevier BV; Volume: 50; Issue: 12 Linguagem: Inglês

10.1016/j.ejso.2024.108568

ISSN

1532-2157

Autores

Felice N van Erning, Teun B M van den Heuvel, F.P.C. Sijtsma, Djamila Boerma, Alexandra R. M. Brandt‐Kerkhof, André J. A. Bremers, Eino B. van Duyn, Helma M. U. van Grevenstein, Patrick Hemmer, Niels F.M. Kok, Eva V. E. Madsen, Philip R. de Reuver, René J. Wiezer, Arjan J Witkamp, Simon W. Nienhuijs, Floris B. Poelmann, Jurriaan B. Tuynman, Lucas B Been, Koen P. Rovers, Ignace H. J. T. de Hingh,

Tópico(s)

Ovarian cancer diagnosis and treatment

Resumo

To improve care for patients with colorectal peritoneal metastases (CRC-PM) or pseudomyxoma peritonei (PMP), the Dutch CRS-HIPEC quality registry was initiated in 2019. The aims are to describe the development and content of this registry and to give insight into the data collected during the first years.

Referência(s)